Interstitial high-dose-rate brachytherapy as salvage treatment for locally recurrent prostate cancer after definitive radiation therapy: Toxicity and 5-year outcome.

Abstract

PURPOSE We report our results with interstitial high-dose-rate brachytherapy (HDR-BT) as a salvage therapy option after external beam therapy with or without BT. Emphasis was put on toxicity and 5-year outcome. METHODS AND MATERIALS From 2003 to 2011, 29 patients with local failure after previous radiotherapy for prostate cancer were treated with salvage… (More)
DOI: 10.1016/j.brachy.2016.09.008

Topics

Cite this paper

@article{Jiang2017InterstitialHB, title={Interstitial high-dose-rate brachytherapy as salvage treatment for locally recurrent prostate cancer after definitive radiation therapy: Toxicity and 5-year outcome.}, author={Ping Jiang and Christof van der Horst and Bernhard N. Kimmig and Fabian Zinsser and Bj{\"{o}rn Poppe and Ulf Luetzen and K P Juenemann and Juergen Dunst and F A Siebert}, journal={Brachytherapy}, year={2017}, volume={16 1}, pages={186-192} }